Treatment of a Gastrointestinal Sarcoidosis Flare: A Multidisciplinary Approach for a Multisystem Disease

23 September 2021 : Case report USA

Unusual or unexpected effect of treatment, Rare disease, Rare coexistence of disease or pathology

Neil Nadpara^1AEF*, Holly S. Greenwald^1AEF, Henry P. Parkman^1E

DOI: 10.12659/AJCR.932494

Am J Case Rep 2021; 22:e932494

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 1. Symptoms, interventions, and outcomes for a patient with gastric sarcoidosis.

Symptom and duration	Prior interventions	Present interventions	Outcomes at follow-up
Two months epigastric pain	PPI therapy, taken intermittently	Steroids, PPI and H2RA, bowel regimen	Reported pain 0/10 epigastric pain
Two months dysphagia	PPI therapy, taken intermittently	Steroids PPI, Speech therapy consultation with education on liquid wash during solid meals	Resolution of symptoms on follow-up
Two months nausea with emesis	PPI therapy, taken intermittently	Steroids, PPI	No antiemetic needed on discharge or at follow-up
PPI – proton pump inhibitor; H2RA – histamine receptor 2 antagonist.

Back to the Article